Summary of Jerash Holdings Conference Call Company Overview - Jerash Holdings is a contract manufacturer located in Jordan, specializing in high-quality apparel for premium global brands. The company operates six factories and produces over 20 million garments annually [4][5]. - The company has a history of strategic growth, including an IPO in 2018 and expansion into PPE manufacturing during the COVID-19 pandemic [6][7]. Customer Base and Sales Dynamics - In 2019, VF Corporation accounted for over 80% of Jerash's sales, primarily through brands like The North Face. As of the last fiscal year, this has decreased to 65%, with projections for the current year indicating a further decline to 54% [10][11]. - New Balance has grown to represent about 12% of sales, with expectations to increase to 14% [11]. Tariff and Competitive Advantages - Jordan's current tariff rate for apparel exports to the US is 15%, significantly lower than competitors like China (70%), Vietnam (38%), and India (64%) [14][15][16]. - Jordan has a duty-free agreement with the EU, allowing for zero tariffs on exports to European countries [18]. Operational Capabilities - Jerash is recognized for its ability to manufacture complex garments, such as jackets and outerwear, which require skilled labor and high-quality control [25][26]. - The company has recently partnered with a major Korean manufacturer, Hansel, to fulfill increased demand, which has fully booked their production capacity [28][30]. Capacity Expansion and Future Growth - All factories are fully booked until summer 2026, indicating strong demand for Jerash's products [34][35]. - The company is considering expanding its capacity through new facilities, with potential costs ranging from $20 million to $30 million for a new building, while a satellite factory in Al Hasa is expected to cost around $2 million [45][47]. Profitability and Capital Expenditure - The growth in production capacity is expected to lower unit costs, enhancing overall profitability [43]. - Minimal capital expenditure is planned for the current fiscal year, focusing on automation and internal expansions [44][45]. Strategic Focus - Jerash is currently prioritizing organic growth over mergers and acquisitions, although it remains open to opportunities if they arise [48]. - The company aims to diversify its geographical sales, with significant growth in the European market and plans to expand into the Middle East [50][51]. Conclusion - Jerash Holdings is well-positioned in the apparel manufacturing industry, leveraging competitive tariff advantages, a strong customer base, and operational capabilities to drive future growth. The focus on capacity expansion and strategic partnerships will be critical in meeting increasing demand and enhancing profitability.

Financial Data and Key Metrics Changes - Net sales for Q1 2025 were $18.9 million, a 17% decrease from $22.7 million in Q1 2024, primarily due to the largest customer transitioning to another supplier [12] - Gross profit for Q1 2025 was $3 million, consistent with Q1 2024, while gross margin increased to 16% from 14% in the same period last year [13] - Net loss for Q1 2025 was $1.5 million, an improvement from a net loss of $1.7 million in Q1 2024 [13] - Cash and cash equivalents decreased to $17.3 million from $21.6 million at the end of 2024, attributed to timing of payments and seasonal expenses [14] Business Line Data and Key Metrics Changes - The addition of a single-use bicarbonate cartridge technology to the product portfolio represents a growth opportunity in the dialysis products market [9] - The company continues to diversify its customer base, signing new contracts with leading hemodialysis providers [5] Market Data and Key Metrics Changes - Approximately 90% of revenue comes from U.S. dialysis providers, with only 10% generated internationally, and only one country is affected by recent U.S. tariff actions [8] - The company is actively pursuing business development opportunities to strengthen its position in the renal market and expand internationally [10] Company Strategy and Development Direction - The company aims to maintain a long-term arrangement with its largest customer, albeit at a smaller scale than previously [20] - Rockwell Medical is focused on expanding its customer base both domestically and internationally, particularly in Latin America and the West Coast of the U.S. [30][31] - The company is optimistic about the at-home dialysis market, which is expected to grow and provide higher margins [24] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges posed by the largest customer's transition but expressed confidence in the guidance provided for 2025 [21] - The second quarter is anticipated to be the low point for revenue, with expectations of improvement in subsequent quarters [22] Other Important Information - The company is monitoring the impact of a recent cyber attack in the industry but has not experienced direct implications on its systems [6] - The company has reiterated its projected guidance for 2025, with net sales expected between $65 million and $70 million [11] Q&A Session Summary Question: What are the scenarios arising from negotiations with the largest customer? - Management indicated that negotiations are ongoing to maintain some level of service, likely at a smaller scale than before [20] Question: What is the revenue cadence expected for the remainder of 2025? - Management stated it is difficult to predict but expressed confidence in the guidance provided, with Q2 likely being the low point [21][22] Question: What is the status of the at-home dialysis market? - The at-home market is progressing as expected, with increasing sales and higher margins anticipated [24] Question: What are the opportunities for international market expansion? - The company sees significant opportunities in Latin America and is exploring expansion into the West Coast of the U.S. [30][31] Question: How much revenue can be replaced from new customers? - Management believes there are enough opportunities among small independent dialysis providers to replace a significant portion of lost revenue [33] Question: Is the revenue guidance based on the current customer base? - Yes, the guidance is based on the current customer base, with potential upside from new customers [35]